About BridgeBio Pharma (BBIO)
BridgeBio Pharma, Inc. is a United States-based company, The Company discovers and develops medicines that target well-characterized genetic diseases. The Company’s product platform divided into three key categories: Mendelian, Oncology and Gene ther... Read more
- USD79.77
- USD80.58
- USD77.84
- USD81.33
- 1.90%
- 354M
- 2.50M
- 15.0B
- 28.33
- 109.90%
Stock News
2 hours ago
Michael Burry flags risks from Japan yen to U.S. stocks as ‘rate check’ stirs debate
MarketWatch
4 hours ago
Did KB Home’s (KBH) New Energy-Efficient Communities and Dividend Move Just Reframe Its Investment Narrative?
Yahoo
7 hours ago
Commodities: Natural Gas And Precious Metals Rally Amid Weather And Geopolitical Threats
SeekingAlpha
7 hours ago
5 Reasons Japan Could Be The Real Risk Markets Are Ignoring
SeekingAlpha